Indocollyre

Indometacin, the active ingredient in Indocollyre, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an ocular solution for topical eye use. It works by inhibiting cyclooxygenase enzymes, thereby decreasing prostaglandin synthesis and alleviating inflammation and pain in postoperative eye inflammation, uveitis, and other ocular inflammatory conditions.

GNH USA supplies Indocollyre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across EU and other markets through rigorous testing.

Indocollyre (indometacin) is used to manage ocular inflammation by inhibiting prostaglandin‑mediated pathways. Post‑operative eye inflammation: reduces swelling, pain and cellular infiltrates following ocular surgery, helping to restore visual comfort. Uveitis: controls intra‑ocular inflammation, decreasing pain, photophobia and risk of tissue damage in anterior or intermediate uveitis. Other ocular inflammatory conditions: alleviates inflammation in conditions such as allergic conjunctivitis or scleritis, improving patient comfort.

Indometacin ocular solution may cause local and systemic adverse reactions, most of which are mild and reversible. Common Side Effects: - Eye irritation or burning sensation: transient discomfort upon instillation. - Redness of the conjunctiva: mild hyperemia that usually resolves. - Tearing or increased lacrimation: temporary watery eyes after dosing. - Blurred vision: short‑term visual disturbance that clears within minutes. Serious or Rare Side Effects: - Corneal ulceration: rare but severe epithelial breakdown requiring immediate medical attention. - Anterior uveitis exacerbation: worsening intra‑ocular inflammation. - Allergic contact dermatitis: localized hypersensitivity reaction around the eye.

When using Indocollyre, consider the following precautions. Avoid use in patients with known hypersensitivity to indometacin or other NSAIDs: discontinue immediately if reaction occurs. Do not administer to eyes with active infection or ulceration: may delay healing. Use with caution in patients with a history of asthma or nasal polyps: risk of bronchospasm. Monitor intra‑ocular pressure in glaucoma patients: NSAIDs can affect pressure. Avoid concomitant use with other topical ophthalmic NSAIDs unless directed: increased risk of toxicity. Store at room temperature: keep in original container, protect from light and moisture.

Indometacin ocular solution can interact with other medicines; monitor accordingly. Major Interactions (Avoid): - Systemic NSAIDs: increased risk of systemic adverse effects such as gastrointestinal bleeding. - Anticoagulants (e.g., warfarin): potentiation of bleeding risk. - Corticosteroid eye drops: may reduce anti‑inflammatory efficacy when combined. Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: possible additive ocular hypotensive effect. - Topical ocular antibiotics: monitor for delayed healing.